SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Angela E. P. Bouwmans, Albert F. G. Leentjens, Werner H. Mess, Wim E. J. Weber, Abnormal Echogenicity of the Substantia Nigra, Raphe Nuclei, and Third-Ventricle Width as Markers of Cognitive Impairment in Parkinsonian Disorders: A Cross-Sectional Study, Parkinson's Disease, 2016, 2016, 1

    CrossRef

  2. 2
    Giacinto Libertini, Nicola Ferrara, Aging of perennial cells and organ parts according to the programmed aging paradigm, AGE, 2016, 38, 2

    CrossRef

  3. 3
    Franc Llorens, Matthias Schmitz, Isidro Ferrer, Inga Zerr, CSF biomarkers in neurodegenerative and vascular dementias, Progress in Neurobiology, 2016, 138-140, 36

    CrossRef

  4. 4
    Nathaniel O. King, Collin J. Anderson, Alan D. Dorval, Deep brain stimulation exacerbates hypokinetic dysarthria in a rat model of Parkinson's disease, Journal of Neuroscience Research, 2016, 94, 2
  5. 5
    Mami Takemoto, Kota Sato, Noriko Hatanaka, Toru Yamashita, Yasuyuki Ohta, Nozomi Hishikawa, Koji Abe, Different Clinical and Neuroimaging Characteristics in Early Stage Parkinson’s Disease with Dementia and Dementia with Lewy Bodies, Journal of Alzheimer's Disease, 2016, 52, 1, 205

    CrossRef

  6. 6
    Alicia Flores-Cuadrado, Isabel Ubeda-Bañon, Daniel Saiz-Sanchez, Carlos de la Rosa-Prieto, Alino Martinez-Marcos, Hippocampal α-synuclein and interneurons in Parkinson's disease: Data from human and mouse models, Movement Disorders, 2016, 31, 4
  7. 7
    S. DeVaughn, E. M. Müller-Oehring, B. Markey, H. M. Brontë-Stewart, T. Schulte, Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention – A Comparison with Parkinson’s Disease, Neuropsychology Review, 2015, 25, 4, 424

    CrossRef

  8. 8
    Aner Weiss, Talia Herman, Nir Giladi, Jeffrey M. Hausdorff, Association between Community Ambulation Walking Patterns and Cognitive Function in Patients with Parkinson’s Disease: Further Insights into Motor-Cognitive Links, Parkinson's Disease, 2015, 2015, 1

    CrossRef

  9. 9
    Lucrezia Islam, Sylvie Piacentini, Paola Soliveri, Silvio Scarone, Orsola Gambini, Capgras delusion for animals and inanimate objects in Parkinson’s Disease: a case report, BMC Psychiatry, 2015, 15, 1

    CrossRef

  10. 10
    Giorgio Tommasi, Mirta Fiorio, Jérôme Yelnik, Paul Krack, Francesca Sala, Emmanuelle Schmitt, Valérie Fraix, Laura Bertolasi, Jean-François Le Bas, Giuseppe Kenneth Ricciardi, Antonio Fiaschi, Jan Theeuwes, Pierre Pollak, Leonardo Chelazzi, Disentangling the Role of Cortico-Basal Ganglia Loops in Top–Down and Bottom–Up Visual Attention: An Investigation of Attention Deficits in Parkinson Disease, Journal of Cognitive Neuroscience, 2015, 27, 6, 1215

    CrossRef

  11. 11
    Yu-Ching Huang, Shwu-Tzy Wu, Juei-Jueng Lin, Che-Chen Lin, Chia-Hung Kao, Prevalence and Risk Factors of Cognitive Impairment in Parkinson Disease, Medicine, 2015, 94, 17, e782

    CrossRef

  12. 12
    Rastislav Šumec, Pavel Filip, Kateřina Sheardová, Martin Bareš, Psychological Benefits of Nonpharmacological Methods Aimed for Improving Balance in Parkinson’s Disease: A Systematic Review, Behavioural Neurology, 2015, 2015, 1

    CrossRef

  13. 13
    Eva M. Müller-Oehring, Edith V. Sullivan, Adolf Pfefferbaum, Neng C. Huang, Kathleen L. Poston, Helen M. Bronte-Stewart, Tilman Schulte, Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson’s disease, Brain Imaging and Behavior, 2015, 9, 3, 619

    CrossRef

  14. 14
    Adriaan R. E. Potgieser, Elizabeth Roosma, Martijn Beudel, Bauke M. de Jong, The Effect of Visual Feedback on Writing Size in Parkinson’s Disease, Parkinson's Disease, 2015, 2015, 1

    CrossRef

  15. 15
    Ning Zhang, Weiguo Liu, Min Ye, Alexander D. Cohen, Yingdong Zhang, The heterogeneity of non-motor symptoms of Parkinson’s disease, Neurological Sciences, 2015, 36, 4, 577

    CrossRef

  16. 16
    Shichun Peng, Yilong Ma, Phoebe G. Spetsieris, Paul Mattis, Andrew Feigin, Vijay Dhawan, David Eidelberg, Characterization of disease-related covariance topographies with SSMPCA toolbox: Effects of spatial normalization and PET scanners, Human Brain Mapping, 2014, 35, 5
  17. 17
    Iván Galtier, Antonieta Nieto, Jesús N. Lorenzo, José Barroso, Cognitive Impairment in Parkinson’s Disease: More than a Frontostriatal Dysfunction, The Spanish Journal of Psychology, 2014, 17,

    CrossRef

  18. 18
    Remco J.J. Knol, Kora de Bruin, Brent Opmeer, Pieter Voorn, Allert J. Jonker, Berthe L.F. van Eck-Smit, Jan Booij, Decreased ipsilateral [123I]iododexetimide binding to cortical muscarinic receptors in unilaterally 6-hydroxydopamine lesioned rats, Nuclear Medicine and Biology, 2014, 41, 1, 90

    CrossRef

  19. 19
    Oskar Hansson, Sara Hall, Annika Öhrfelt, Henrik Zetterberg, Kaj Blennow, Lennart Minthon, Katarina Nägga, Elisabet Londos, Shiji Varghese, Nour K Majbour, Abdulmonem Al-Hayani, Omar MA El-Agnaf, Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease, Alzheimer's Research & Therapy, 2014, 6, 3, 25

    CrossRef

  20. 20
    A. Hanganu, C. Bedetti, C. Degroot, B. Mejia-Constain, A.-L. Lafontaine, V. Soland, S. Chouinard, M.-A. Bruneau, S. Mellah, S. Belleville, O. Monchi, Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally, Brain, 2014, 137, 4, 1120

    CrossRef

  21. 21
    Linda Dauwerse, Annette Hendrikx, Karen Schipper, Chris Struiksma, Tineke A. Abma, Quality-of-life of patients with Parkinson’s disease, Brain Injury, 2014, 28, 10, 1342

    CrossRef

  22. 22
    Banu Ozen Barut, Dilek Ince Gunal, Çiğdem Turkmen, Aynur Mollahasanoğlu, Handan Ankaralı, Clinical and cognitive profiles of patients with both Parkinson’s disease and essential tremor, Acta Neurologica Belgica, 2013, 113, 2, 117

    CrossRef

  23. 23
    Il-Hwan Choe, Sujung Yeo, Kyung-Cheon Chung, Sung-Hoon Kim, Sabina Lim, Decreased and increased cerebral regional homogeneity in early Parkinson's disease, Brain Research, 2013, 1527, 230

    CrossRef

  24. 24
    James Gratwicke, Joshua Kahan, Ludvic Zrinzo, Marwan Hariz, Patricia Limousin, Thomas Foltynie, Marjan Jahanshahi, The nucleus basalis of Meynert: A new target for deep brain stimulation in dementia?, Neuroscience & Biobehavioral Reviews, 2013, 37, 10, 2676

    CrossRef

  25. 25
    Laurie K. Mischley, Kelly Jennings, Peter B. Bongiorno, Pina LoGiudice, Textbook of Natural Medicine, 2013,

    CrossRef

  26. 26
    Sion Williams, John Keady, Centre Stage Diagramming: Late-stage Parkinson’s disease and Alzheimer’s disease, Journal of Aging Studies, 2012, 26, 2, 204

    CrossRef

  27. 27
    Hanna S. Lindgren, Stephen B. Dunnett, Cognitive dysfunction and depression in Parkinson’s disease: what can be learned from rodent models?, European Journal of Neuroscience, 2012, 35, 12
  28. 28
    María A. Fernández-Seara, Elisa Mengual, Marta Vidorreta, Maite Aznárez-Sanado, Francis R. Loayza, Federico Villagra, Jaione Irigoyen, María A. Pastor, Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI, NeuroImage, 2012, 59, 3, 2743

    CrossRef

  29. 29
    Irene Litvan, Jennifer G. Goldman, Alexander I. Tröster, Ben A. Schmand, Daniel Weintraub, Ronald C. Petersen, Brit Mollenhauer, Charles H. Adler, Karen Marder, Caroline H. Williams-Gray, Dag Aarsland, Jaime Kulisevsky, Maria C. Rodriguez-Oroz, David J. Burn, Roger A. Barker, Murat Emre, Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines, Movement Disorders, 2012, 27, 3
  30. 30
    Kathleen L. Poston, David Eidelberg, Functional brain networks and abnormal connectivity in the movement disorders, NeuroImage, 2012, 62, 4, 2261

    CrossRef

  31. 31
    Stefan Lehnert, Sarah Jesse, Wolfgang Rist, Petra Steinacker, Hilkka Soininen, Sanna-Kaisa Herukka, Hayrettin Tumani, Martin Lenter, Patrick Oeckl, Boris Ferger, Bastian Hengerer, Markus Otto, iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia, Experimental Neurology, 2012, 234, 2, 499

    CrossRef

  32. 32
    N. S. Narayanan, B. B. Land, J. E. Solder, K. Deisseroth, R. J. DiLeone, Prefrontal D1 dopamine signaling is required for temporal control, Proceedings of the National Academy of Sciences, 2012, 109, 50, 20726

    CrossRef

  33. 33
    Sarah Vanhoutte, Miet De Letter, Paul Corthals, John Van Borsel, Patrick Santens, Quantitative analysis of language production in Parkinson's disease using a cued sentence generation task, Clinical Linguistics & Phonetics, 2012, 26, 10, 863

    CrossRef

  34. 34
    C. Pellicano, F. Assogna, F. Piras, C. Caltagirone, F. E. Pontieri, G. Spalletta, Regional cortical thickness and cognitive functions in non-demented Parkinson’s disease patients: a pilot study, European Journal of Neurology, 2012, 19, 1
  35. 35
    P. Shotbolt, J. Moriarty, A. Costello, A. Jha, A. David, K. Ashkan, M. Samuel, Relationships between deep brain stimulation and impulse control disorders in Parkinson’s disease, with a literature review, Parkinsonism & Related Disorders, 2012, 18, 1, 10

    CrossRef

  36. You have free access to this content36
    Giovanni Esposito, Fernandes Ana Clara, Patrik Verstreken, Synaptic vesicle trafficking and Parkinson's disease, Developmental Neurobiology, 2012, 72, 1
  37. 37
    Seo Hee Choi, Tae Min Jung, Ji E. Lee, Seung-Koo Lee, Young H. Sohn, Phil Hyu Lee, Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status, Neurobiology of Aging, 2012, 33, 7, 1265

    CrossRef

  38. 38
    J. Kulisevsky, J. Pagonabarraga, G. Llebaria, B. Hernández, J. Arranz, Evaluación de la satisfacción médico/paciente con el uso del “Parkinson's Disease Dementia-Short-Screen” (PDD-SS): un test de cribado para la demencia en la enfermedad de Parkinson (estudio DIFUSION), Neurología, 2011, 26, 8, 461

    CrossRef

  39. 39
    J. Kulisevsky, J. Pagonabarraga, G. Llebaria, B. Hernández, J. Arranz, Evaluation of doctor/patient satisfaction with the use of the Parkinson's Disease Dementia-Short-Screen (PDD-SS): a screening test for dementia in Parkinson's disease (DIFFUSION study), Neurología (English Edition), 2011, 26, 8, 461

    CrossRef

  40. 40
    R. Deschamps, A. Moulignier, A.-C. Viret, Mémoire et ses troubles, EMC - Neurologie, 2011, 8, 2, 1

    CrossRef

  41. 41
    A. Merola, M. Zibetti, S. Angrisano, L. Rizzi, V. Ricchi, C. A. Artusi, M. Lanotte, M. G. Rizzone, L. Lopiano, Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients, Brain, 2011, 134, 7, 2074

    CrossRef

  42. 42
    Michał K. Owecki, Sławomir Michalak, Wojciech Kozubski, Psychopatologia chorób układu nerwowego w wieku podeszłym, Neurologia i Neurochirurgia Polska, 2011, 45, 2, 161

    CrossRef

  43. 43
    Sook K. Song, Ji E. Lee, Hae-Jeong Park, Young H. Sohn, Jong Doo Lee, Phil Hyu Lee, The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status, Movement Disorders, 2011, 26, 2
  44. 44
    P. Borghammer, K. Østergaard, P. Cumming, A. Gjedde, A. Rodell, N. Hall, M. M. Chakravarty, A deformation-based morphometry study of patients with early-stage Parkinson’s disease, European Journal of Neurology, 2010, 17, 2
  45. 45
    Maren E. Bodden, Brit Mollenhauer, Claudia Trenkwalder, Nicole Cabanel, Karla Maria Eggert, Marcus Michael Unger, Wolfgang Hermann Oertel, Josef Kessler, Richard Dodel, Elke Kalbe, Affective and cognitive theory of mind in patients with parkinson’s disease, Parkinsonism & Related Disorders, 2010, 16, 7, 466

    CrossRef

  46. 46
    AUDREY MCKINLAY, RANDOLPH C. GRACE, JOHN C. DALRYMPLE-ALFORD, DEREK ROGER, Characteristics of executive function impairment in Parkinson’s disease patients without dementia, Journal of the International Neuropsychological Society, 2010, 16, 02, 268

    CrossRef

  47. 47
    Meirav Balas, Yacov Balash, Nir Giladi, Tanya Gurevich, Cognition in multiple system atrophy: neuropsychological profile and interaction with mood, Journal of Neural Transmission, 2010, 117, 3, 369

    CrossRef

  48. 48
    Jamie Reilly, Amy D. Rodriguez, Martine Lamy, Jean Neils-Strunjas, Cognition, language, and clinical pathological features of non-Alzheimer's dementias: An overview, Journal of Communication Disorders, 2010, 43, 5, 438

    CrossRef

  49. You have free access to this content49
    Flavio Nobili, Claudio Campus, Dario Arnaldi, Fabrizio De Carli, Gaia Cabassi, Andrea Brugnolo, Barbara Dessi, Silvia Morbelli, Gianmario Sambuceti, Giovanni Abbruzzese, Guido Rodriguez, Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: A [I-123]FP-CIT SPECT study, Movement Disorders, 2010, 25, 1
  50. 50
    Maren Carbon, Kathrin Reetz, M. Felice Ghilardi, Vijay Dhawan, David Eidelberg, Early Parkinson's disease: Longitudinal changes in brain activity during sequence learning, Neurobiology of Disease, 2010, 37, 2, 455

    CrossRef

  51. 51
    Christian Beste, Rita Willemssen, Carsten Saft, Michael Falkenstein, Response inhibition subprocesses and dopaminergic pathways: Basal ganglia disease effects, Neuropsychologia, 2010, 48, 2, 366

    CrossRef

  52. 52
    K. Beyer, M. Domingo-Sabat, C. Santos, E. Tolosa, I. Ferrer, A. Ariza, The decrease of  -synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies, Brain, 2010, 133, 12, 3724

    CrossRef

  53. You have free access to this content53
    Maren Elisabeth Bodden, Richard Dodel, Elke Kalbe, Theory of mind in Parkinson's disease and related basal ganglia disorders: A systematic review, Movement Disorders, 2010, 25, 1
  54. 54
    Glenda Halliday, Karen Murphy, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  55. 55
    Jolyon Meara, Brocklehurst's Textbook of Geriatric Medicine and Gerontology, 2010,

    CrossRef

  56. 56
    Dirk W. Luchtman, Di Shao, Cai Song, Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease, Physiology & Behavior, 2009, 98, 1-2, 130

    CrossRef

  57. 57
    Inga Liepelt, Matthias Reimold, Walter Maetzler, Jana Godau, Gerald Reischl, Alexandra Gaenslen, Heinz Herbst, Daniela Berg, Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration—[18F]FDG-PET, Movement Disorders, 2009, 24, 10
  58. 58
    Arthur Kummer, Estefânia Harsányi, Fernando M.V. Dias, Francisco Cardoso, Paulo Caramelli, Antônio Lúcio Teixeira, Depression Impairs Executive Functioning in Parkinson Disease Patients With Low Educational Level, Cognitive and Behavioral Neurology, 2009, 22, 3, 167

    CrossRef

  59. 59
    Alessandra Graziottin, Audrey Serafini, Depressione e climaterio, Quaderni Italiani di Psichiatria, 2009, 28, 1, 34

    CrossRef

  60. 60
    Frank Euteneuer, Florian Schaefer, Ralf Stuermer, Wolfram Boucsein, Lars Timmermann, Michael T. Barbe, Georg Ebersbach, Jörg Otto, Josef Kessler, Elke Kalbe, Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: A neuropsychological and psychophysiological study, Neuropsychologia, 2009, 47, 13, 2882

    CrossRef

  61. 61
    Christian Beste, Isabel Dziobek, Horst Hielscher, Rita Willemssen, Michael Falkenstein, Effects of stimulus–response compatibility on inhibitory processes in Parkinson’s disease, European Journal of Neuroscience, 2009, 29, 4
  62. 62
    Esen Saka, Bülent Elibol, Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction, Parkinsonism & Related Disorders, 2009, 15, 9, 688

    CrossRef

  63. 63
    Stefano Zoccolella, Claudia dell'Aquila, Giovanni Abruzzese, Angelo Antonini, Ubaldo Bonuccelli, Margherita Canesi, Silvano Cristina, Roberta Marchese, Claudio Pacchetti, Roberto Zagaglia, Giancarlo Logroscino, Giovanni Defazio, Paolo Lamberti, Paolo Livrea, Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia, Movement Disorders, 2009, 24, 7
  64. 64
    Anna Gómez, Isidre Ferrer, Increased oxidation of certain glycolysis and energy metabolism enzymes in the frontal cortex in Lewy body diseases, Journal of Neuroscience Research, 2009, 87, 4
  65. You have free access to this content65
    Sarah Jesse, Petra Steinacker, Stefan Lehnert, Frank Gillardon, Bastian Hengerer, Markus Otto, Neurochemical Approaches in the Laboratory Diagnosis of Parkinson and Parkinson Dementia Syndromes: A Review, CNS Neuroscience & Therapeutics, 2009, 15, 2
  66. 66
    Walter Maetzler, Inga Liepelt, Daniela Berg, Progression of Parkinson's disease in the clinical phase: potential markers, The Lancet Neurology, 2009, 8, 12, 1158

    CrossRef

  67. 67
    Shilpa Chitnis, Jayaraman Rao, Rivastigmine in Parkinson's disease dementia, Expert Opinion on Drug Metabolism & Toxicology, 2009, 5, 8, 941

    CrossRef

  68. 68
    Michail E. Kalaitzakis, Ronald K. B. Pearce, The morbid anatomy of dementia in Parkinson’s disease, Acta Neuropathologica, 2009, 118, 5, 587

    CrossRef

  69. 69
    Lucian Hritcu, Alin Ciobica, Vlad Artenie, Effects of right-unilateral 6-hydroxydopamine infusion-induced memory impairment and oxidative stress: relevance for Parkinson’s disease, Open Life Sciences, 2008, 3, 3

    CrossRef

  70. 70
    Murray Hong, Karim Mukhida, Ivar Mendez, GDNF therapy for Parkinson’s disease, Expert Review of Neurotherapeutics, 2008, 8, 7, 1125

    CrossRef

  71. 71
    Marc D. Pell, Laura Monetta, How Parkinson's Disease Affects Non-verbal Communication and Language Processing, Language and Linguistics Compass, 2008, 2, 5
  72. 72
    Mario Ezquerra, Jaume Campdelacreu, Carles Gaig, Yaroslau Compta, Esteban Muñoz, Maria Jose Martí, Francesc Valldeoriola, Eduardo Tolosa, Lack of association of APOE and tau polymorphisms with dementia in Parkinson’s disease, Neuroscience Letters, 2008, 448, 1, 20

    CrossRef

  73. 73
    Laura L. Murray, LANGUAGE AND PARKINSON'S DISEASE, Annual Review of Applied Linguistics, 2008, 28, 113

    CrossRef

  74. 74
    Richard Dodel, Ilona Csoti, Georg Ebersbach, Gerd Fuchs, Matthias Hahne, Wilfried Kuhn, Matthias Oechsner, Wolfgang Jost, Heinz Reichmann, Jörg B. Schulz, Lewy body dementia and Parkinson’s disease with dementia, Journal of Neurology, 2008, 255, S5, 39

    CrossRef

  75. 75
    Katherine E. Soderstrom, Shilpa Ramaswamy, C. Warren Olanow, Jeffrey H. Kordower, Animal Models of Parkinson's Disease: The Non-Motor and Non-Dopaminergic Features,